The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
about
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaRecent advances of highly selective CDK4/6 inhibitors in breast cancerCDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrestEffect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity.Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.The PI3K Pathway in Human Disease.Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateMolecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line
P2860
Q28074691-3654BA1B-0E17-41B1-85DD-7356BE384041Q33602076-820AF92B-2C7F-42B2-B63E-72CBE322CF92Q33759276-8DB1CBAE-7C6D-4FA6-A542-F8224D4993EFQ40546450-7FB7E219-CA89-4620-B46F-A3735A9949B2Q45065453-F0A1330C-CD4B-4C3E-AEE7-DF83BCF15FB4Q46546002-937CC501-2E66-420D-A454-F437F7189DF3Q47098975-88F7B4D0-FC05-4CAE-8455-96D772E15FA8Q48088749-A90BB6A9-E1A0-4C9D-814B-0B0F58EAA1EFQ56378380-E8F6EAD4-4CD0-4993-A77F-7424A136ADEAQ59128140-FB2EBD7F-4E37-4303-817E-13110267BC17
P2860
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The CDK4/6 inhibitor LY2835219 ...... d neck squamous cell carcinoma
@en
The CDK4/6 inhibitor LY2835219 ...... neck squamous cell carcinoma.
@nl
type
label
The CDK4/6 inhibitor LY2835219 ...... d neck squamous cell carcinoma
@en
The CDK4/6 inhibitor LY2835219 ...... neck squamous cell carcinoma.
@nl
prefLabel
The CDK4/6 inhibitor LY2835219 ...... d neck squamous cell carcinoma
@en
The CDK4/6 inhibitor LY2835219 ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The CDK4/6 inhibitor LY2835219 ...... d neck squamous cell carcinoma
@en
P2093
Jin Seok Ahn
Jong-Mu Sun
Keunchil Park
Myung-Ju Ahn
Se-Hoon Lee
Seong Yoon Yi
Yeon-Hee Bae
P2860
P304
14803-14813
P356
10.18632/ONCOTARGET.7543
P407
P577
2016-02-21T00:00:00Z